SIMS ANDREW JOHN HUGH MACINTYRE (Chief Financial Officer) purchased 41.5% of their position (20K shares) of PLUS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/5/2025ACC: 0001193125-25-265866
Officer· Chief Financial Officer
Since Feb 2020
+20K
Net shares
Net buyer
$10.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$0.51
Trade value
$10.20K
% of position
41.5%
11/4/2025
48.14K→68.14K
Total
Net shares
+20K
Net value
$10.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/4/2025 | P · Purchase | +20K | $0.51 | $10.20K | 41.5% | 48.14K | 68.14K |
| Total | +20K | $10.20K | ||||||
Derivative Transactions0
No derivative transactions reported